bioRxiv·31 AugCerebrospinal fluid YWHAG:NPTX2 ratio predicts clinical severity and future phenoconversion in frontotemporal lobar degenerationPreprint: cohort study in peopleBiomarkersPaper
AAIC 2025 Abstract·11 JanLarge‐scale cerebrospinal fluid proteomics identifies molecular signatures of disease progression across Alzheimer's disease and sporadic frontotemporal lobar degenerationStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·8 JanBuilding infrastructure to support biospecimen and data use as part of the UCSF Memory and Aging Center's ADRCStudy in peopleAI & dataPaper
AAIC 2025 Abstract·26 DecClinical associations of CSF TMEM106B in familial and sporadic frontotemporal lobar degenerationStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecEvaluation of a Novel Home‐Based Pathway to Support Early Detection and Diagnosis of Alzheimer's DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecTargeted proteomics via NULISAseq identifies blood‐detectable markers of disease progression in familial frontotemporal lobar degenerationStudy in peopleBiomarkersPaper